GENESOFT PHARMACEUTICALS INC has a total of 26 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are HUA MEDICINE, DISARM THERAPEUTICS INC and SEAL ROCK THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Burli Roland W | 20 |
#2 | Kaizerman Jacob A | 15 |
#3 | Baird Eldon E | 15 |
#4 | Jones Peter | 11 |
#5 | Mcminn Dustin L | 11 |
#6 | Taylor Matthew J | 9 |
#7 | Hu Wenhao | 8 |
#8 | Buerli Roland W | 6 |
#9 | Jiang Chun | 5 |
#10 | Ge Yigong | 4 |
Publication | Filing date | Title |
---|---|---|
AU2003285958A1 | Anti-infective biaryl compounds | |
CA2494139A1 | Biaryl compounds having anti-infective activity | |
US2003211508A1 | Charged compounds comprising a nucleic acid binding moiety and uses therefor | |
US2003191168A1 | Aryl-benzimidazole compounds having antiinfective activity | |
US2003083268A1 | Isoquinoline compounds having antiinfective activity | |
US2003130198A1 | Halogen-substitued thienyl compounds |